Cloudbreak Therapeutics

About:

Cloudbreak Therapeutics is a clinical stage biotechnology company

Website: http://cloudbreaktherapeutics.com

Top Investors: CDH Investments, Industrial Securities Capital, CCB International, BOC International Holdings, Yingke Capital

Description:

Cloudbreak Therapeutics is a clinical-stage biotechnology company focusing on ocular drug development. Cloudbreak Therapeutics operates a capital efficient business model based upon VIC + 505b(2). We repurpose approved systemic drugs for ocular delivery to treat eye diseases and quickly advance drug candidates to complete proof-of-concept (POC) Phase II clinical trials and to out-license global rights for Phase III clinical trials, product registration, and commercialization. Fully embracing the pharmaceutical development ecosystem, we utilize contract research organizations (CRO) for non-clinical, CMC and clinical development to efficiently maximize capital for drug development.